Welcome! Click course links to visit the site sponsoring the free CME courses for Physicians. All courses are FREE & approved for AMA Pra CAT 1 credit required for Physician license renewal in most states. Posts are current and include expiration dates if applicable.

Case Explorations in the Treatment of Schizophrenia



Case Explorations in the Treatment of Schizophrenia: A Clinical CliffhangersSM Series- a free online CME activity designed to help physicians explore the benefits and limitations of various therapeutic options available for use in schizophrenia, including the role of long-acting injectable antipsychotics (LAIAs) and strategies to improve treatment adherence and patient–physician communication. 1-Considerations for the Selection of Initial Maintenance Treatment After a First Psychotic Episode in a Patient With Schizophrenia- Watch the first of three Webcasts that explores effective treatment strategies for patients with schizophrenia. In this first Webisode, faculty expert John Lauriello, MD, explores treatment options for a patient with probable schizophrenia, including appropriate timing for the introduction of long-acting injectables. 2-Addressing Patient and Clinician Barriers to the Use of Long-Acting Injectable Antipsychotics in Schizophrenia- Watch the second of three Webcasts that explores effective treatment strategies for patients with schizophrenia. In this second Webisode, faculty expert John Lauriello, MD, discusses the impact of medication nonadherence in schizophrenia and the potential role of long-acting injectable antipsychotics. 3-Relapse in Schizophrenia: Charting an Optimal Path Forward- Watch the last of three Webcasts that explores effective treatment strategies for patients with schizophrenia. In this final Webisode, faculty expert John Lauriello, MD, evaluates data about proven methods for improving medication adherence and the benefits and limitations of long-acting injectable antipsychotics.

1.5 Free AMA Pra CAT 1 CME for Physicians

Expires 7/10/15
Med-IQ      This activity is supported by an educational grant from Otsuka America Pharmaceutical, Inc.